Compare Applovin Corporation (APP) vs Oscar Health Inc (OSCR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Applovin Corporation vs Oscar Health Inc — how do they compare? Applovin Corporation trades at $507.47 (market cap $170.31B), while Oscar Health Inc trades at $30.43 (market cap $9.21B). The key difference: Applovin Corporation is far larger — about 18.5× Oscar Health Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, Applovin Corporation nearer its low. Which is the better fit depends on your goals.
| APP | OSCR | |
|---|---|---|
Market Cap | $170.31B | $9.21B |
Sector | Technology | Health |
52-Week High | $733.60 | $32.18 |
52-Week Low | $335.10 | $10.85 |
Enterprise Value | $171.07B | $4.83B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AppLovin trades at $506.98, down 2.58% today, with a bullish technical setup near pivot point support at $504. The company shows exceptional fundamentals with 59% revenue growth in Q1 2026 and net margins exceeding 64%. Analyst consensus remains strongly bullish with an $644.09 price target, supported by expanding e-commerce advertising share and AI-driven platform growth noted in recent Jefferies research.
The outlook remains positive given consistent earnings beats and projected revenue growth to $6.2B in 2026. Primary risks include premium valuation multiples (P/E 44.09) and competitive pressure in mobile advertising. The stock offers growth exposure but requires monitoring of execution against high expectations.
OSCR trades at $30.54, down 2.12% today but up significantly year-to-date. Technicals are bullish with moving averages supporting the uptrend, while oscillators show neutral momentum. Fundamentally, revenue grew to $11.70B in 2025 with a net loss of $443M, but 2026 guidance projects improved profitability. Recent news highlights strong Q1 2026 earnings beat and reaffirmed growth targets at industry conferences.
Outlook remains optimistic due to strong revenue growth and operational improvements, but risks include persistent net losses and competitive pressures. Analyst consensus is mixed with a $22.50 price target below current levels, suggesting cautious optimism amid execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applovin Corporation
AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.
Read more on APP →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
